Humacyte HUMA Income Statement (2020-2026)

NASDAQ HUMA
$0.68 -0.05 (-6.85%)
At close: Aug 20, 2026 · 4:00 PM EDT
Income Statement Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Shares Outstanding (Entity) (Quarter)
43.95M39.97M103.00M103.01M103.10M103.23M103.33M103.41M103.46M103.67M119.08M119.35M119.84M130.03M155.12M156.34M158.84M158.16M222.02M277.80M
Revenue & cost
Revenue (Quarter)
0.24M0.52M0.30M0.75M0.47M0.49M0.41M
Gross Profit (Quarter)
0.37M0.09M0.49M-8.62M-1.54M-0.82M
Operating items
Research & Development (Quarter)
15.39M16.25M16.31M14.65M17.34M14.96M17.28M20.54M18.55M20.18M21.26M23.75M22.93M20.66M15.42M22.01M17.27M14.61M19.46M18.14M
Selling, General & Administrative (Quarter)
5.40M5.55M5.68M5.18M6.19M5.83M5.23M6.19M6.07M6.00M5.31M5.75M7.31M7.43M8.14M7.81M7.61M7.62M7.93M8.03M
Other Operating Expenses (Quarter)
0.15M0.21M0.26M9.08M2.04M1.23M
Operating Expenses (Quarter)
20.78M21.80M22.00M19.83M23.52M20.79M22.51M26.73M24.62M26.18M26.58M29.50M30.23M28.09M23.70M30.03M25.14M31.30M29.43M27.40M
Operating Income (Quarter)
-20.54M-21.62M-21.80M-18.53M-23.49M-20.80M-22.50M-26.73M-24.62M-26.14M-26.60M-29.50M-30.23M-28.09M-23.20M-29.73M-24.39M-30.84M-28.90M-27.00M
EBIT (Quarter)
-20.54M-21.62M-21.80M-18.53M-23.49M-20.80M-22.50M-26.73M-24.62M-26.14M-26.60M-29.50M-30.23M-28.09M-23.20M-29.73M-24.39M-30.84M-28.90M-27.00M
Non-operating items
Non Operating Investment Income (Quarter)
Interest & Investment Income (Quarter)
0.00M0.01M0.03M0.30M0.88M1.41M1.48M1.48M1.37M1.14M1.03M1.31M0.91M0.85M0.66M0.83M0.59M0.50M0.33M0.39M
Other Non Operating Income (Quarter)
0.42M-0.04M-2.40M-0.14M-2.19M0.06M-0.39M1.05M3.20M14.93M-0.75M4.01M-40.46M8.53M-5.16M
Non Operating Income (Quarter)
-11.02M64.21M1.93M55.40M-1.79M17.07M-14.46M4.03M-1.37M1.08M-5.32M-27.16M-8.97M7.15M62.32M-7.93M6.88M6.03M11.32M-9.81M
Net income details
EBT (Quarter)
-31.56M-23.00M-29.80M-19.72M-24.25M-21.02M-22.72M-26.96M-24.72M-29.98M-27.39M-30.70M-31.76M-29.34M-25.54M-31.44M-86.02M-30.92M-30.84M-28.93M
Profit After Tax (Quarter)
-31.56M42.59M-19.83M36.87M-25.28M-3.72M-36.97M-22.71M-26.00M-25.11M-31.90M-56.66M-39.20M-20.94M39.14M-37.66M-17.51M-24.80M-17.62M-36.80M
Income from Continuing Operations (Quarter)
-31.56M-23.00M-29.80M-19.72M-24.25M-21.02M-22.72M-26.96M-24.72M-29.98M-27.39M-30.70M-31.76M-29.34M-25.54M-31.44M-86.02M-30.92M-30.84M-28.93M
Consolidated Net Income (Quarter)
-31.56M-23.00M-29.80M-19.72M-24.25M-21.02M-22.72M-26.96M-24.72M-29.98M-27.39M-30.70M-31.76M-29.34M-25.54M-31.44M-86.02M-30.92M-30.84M-28.93M
Income towards Parent Company (Quarter)
-31.56M-23.00M-29.80M-19.72M-24.25M-21.02M-22.72M-26.96M-24.72M-29.98M-27.39M-30.70M-31.76M-29.34M-25.54M-31.44M-86.02M-30.92M-30.84M-28.93M
Net Income towards Common Stockholders (Quarter)
-31.56M-23.00M-29.80M-19.72M-24.25M-21.02M-22.72M-26.96M-24.72M-29.98M-27.39M-30.70M-31.76M-29.34M-25.54M-31.44M-86.02M-30.92M-30.84M-28.93M
Additional items
EPS (Basic) (Quarter)
-0.72-0.58-0.29-0.19-0.24-0.20-0.22-0.26-0.24-0.29-0.25-0.26-0.27-0.25-0.19-0.20-0.54-0.20-0.16-0.15
EPS (Diluted) (Quarter)
-0.72-0.58-0.29-0.19-0.24-0.20-0.22-0.26-0.24-0.29-0.25-0.26-0.27-0.25-0.19-0.20-0.54-0.20-0.16-0.15
Shares Outstanding (Quarter)
43.95M39.97M103.00M103.01M103.03M103.05M103.26M103.36M103.44M103.42M108.25M119.17M119.41M118.48M131.50M155.44M158.31M158.16M197.85M197.85M
Shares Outstanding (Diluted) (Quarter)
43.95M39.97M103.00M103.91M103.03M103.05M103.26M103.36M103.44M103.42M108.25M119.17M119.41M118.48M131.76M155.44M158.31M158.16M197.85M197.85M
EBITDA (Quarter)
-20.54M-21.62M-21.80M-18.53M-23.49M-20.80M-22.50M-26.73M-24.62M-26.14M-26.60M-29.50M-30.23M-28.09M-23.20M-29.73M-24.39M-30.84M-28.90M
Interest Expenses (Quarter)
26.70M1.40M8.03M1.49M1.64M1.64M1.70M1.71M1.46M4.99M1.82M2.52M2.44M2.10M3.00M2.54M62.22M0.59M2.27M